Precigen (PGEN) Shares Issued (2012 - 2026)

Precigen (PGEN) reported Shares Issued of $255000.0 for Q1 2026, up 171.83% year-over-year from $93808.3 in Q1 2025, and up 82.14% quarter-over-quarter from $140000.0 in Q4 2025.

Precigen (PGEN) Shares Issued (2012 - 2026) Analysis & Trends

Precigen (PGEN) has 14 years of Shares Issued data on file, last reported at $255000.0 in Q1 2026.

  • Shares Issued for Q1 2026 came in at $255000.0, up 171.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 million (down 94.13% YoY), and the FY2025 annual result was $1.2 million, down 96.15% from the prior year.
  • Shares Issued climbed to $255000.0 in Q1 2026 per PGEN's latest filing, from $140000.0 in the prior quarter.
  • Over five years, Shares Issued peaked at $73.5 million in Q1 2023 and troughed at -$73.5 million in Q2 2023.
  • A 4-year average of $10.6 million and a median of $274500.0 in 2024 frame the typical range for Shares Issued.
  • The sharpest annual moves came in 2024 and 2025: Shares Issued slumped 99.6% in 2024, then surged 381.97% in 2025.
  • A 4-year view of Shares Issued shows it stood at $72.8 million in 2023, then tumbled by 57.57% to $30.9 million in 2024, then slumped by 99.55% to $140000.0 in 2025, then surged by 82.14% to $255000.0 in 2026.
  • Business Quant data shows PGEN's Shares Issued at $255000.0 in Q1 2026, $140000.0 in Q4 2025, and $1.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 5.40 Mn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 27.00 Mn
9 Abivax 94.37 Bn 94.37 Bn - 26,927.15
10 Precigen 1.27 Bn 1.27 Bn 20.69 Mn 255,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 255,000.00
Mar 31, 2026 255,000.00
Dec 31, 2025 140,000.00
Dec 31, 2025 140,000.00
Sep 30, 2025 1.42 Mn
Sep 30, 2025 1.42 Mn
Mar 31, 2025 -355,000.00
Mar 31, 2025 -355,000.00
Dec 31, 2024 30.89 Mn
Dec 31, 2024 30.89 Mn
Sep 30, 2024 294,000.00
Sep 30, 2024 294,000.00
Jun 30, 2024 52,000.00
Jun 30, 2024 52,000.00
Sep 30, 2023 72.81 Mn
Sep 30, 2023 72.81 Mn
Jun 30, 2023 -73.50 Mn
Jun 30, 2023 -73.50 Mn
Mar 31, 2023 73.50 Mn
Mar 31, 2023 73.50 Mn